RT Book, Section A1 Choti, Michael A. A2 Zinner, Michael J. A2 Ashley, Stanley W. SR Print(0) ID 57017607 T1 Chapter 45. Hepatic Colorectal Metastases: Resection, Pumps, and Ablation T2 Maingot's Abdominal Operations, 12e YR 2013 FD 2013 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-163388-8 LK accesssurgery.mhmedical.com/content.aspx?aid=57017607 RD 2024/03/28 AB Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the United States.1 In spite of an increasing emphasis on screening and prevention of this disease, more than 140,000 new cases will have been diagnosed in 2010, comprising approximately 10% of new cancer diagnoses. Although mortality from this disease has improved over the past two decades, more than 40% of patients with colorectal cancer eventually die of their cancer.1,2 Among those patients with advanced disease, more than half will develop liver metastases, more than any other organ, and many will have disease recognizably confined to this organ. Specifically, approximately 20–40% of patients with metastatic CRC have liver-only metastases at the time of presentation or recurrence, accounting for about 30,000 patients per year in the United States.3,4